3.9 Article

Treatment-resistant bipolar depression: concepts and challenges for novel interventions

Journal

BRAZILIAN JOURNAL OF PSYCHIATRY
Volume 44, Issue 2, Pages 178-186

Publisher

ASSOC BRASILEIRA PSIQUIATRIA
DOI: 10.1590/1516-4446-2020-1627

Keywords

Bipolar disorder; depression; treatment-resistant bipolar disorder; definition; treatment-resistant bipolar depression (TRBD)

Categories

Funding

  1. Brain & Behavior Research Foundation

Ask authors/readers for more resources

Treatment-resistant bipolar depression (TRBD) is common in patients with bipolar disorders, but there are limited interventions. This review identified promising new interventions for TRBD, including both pharmacological and non-pharmacological treatments. More research is needed to personalize current treatments.
Treatment-resistant bipolar depression (TRBD) has been reported in about one-quarter of patients with bipolar disorders, and few interventions have shown clear and established effectiveness. We conducted a narrative review of the published medical literature to identify papers discussing treatment-resistant depression concepts and novel interventions for bipolar depression that focus on TRBD. We searched for potentially relevant English-language articles published in the last decade. Selected articles (based on the title and abstract) were retrieved for a more detailed evaluation. A number of promising new interventions, both pharmacological and non-pharmacological, are being investigated for TRBD treatment, including ketamine, lurasidone, D-cycloserine, pioglitazone, N-acetylcysteine, angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers, cyclooxygenase 2 inhibitors, magnetic seizure therapy, intermittent theta-burst stimulation, deep transcranial magnetic stimulation, vagus nerve stimulation therapy, and deep brain stimulation. Although there is no consensus about the concept of TRBD, better clarification of the neurobiology associated with treatment non-response could help identify novel strategies. More research is warranted, mainly focusing on personalizing current treatments to optimize response and remission rates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available